Skip to content
Activity & longevityTrial meta-analysis3 min read

Exercise linked to better thinking and daily function in Alzheimer's disease: 16 trials

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Physical Activity Improves Cognition and Activities of Daily Living in Adults with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. · International journal of environmental research and public health · 2022 · Original paper ↗

Key takeaway

Pooling 16 randomized trials with 945 participants aged 70 to 88 years, physical activity was associated with better global cognition (SMD 0.41, 95% CI 0.24-0.58) and activities of daily living (SMD 0.56, 95% CI 0.32-0.79) in people with Alzheimer's disease. The abstract does not describe the quality of the trials or how much results varied between them.

Study design

Trial meta-analysis

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

There is no cure for Alzheimer's disease, so non-drug approaches matter. The authors set out to pool randomized trials to see whether physical activity improves cognition and activities of daily living in people with the disease.

Who and how

Systematic review and meta-analysis of randomized controlled trials comparing physical activity with a control condition in people with Alzheimer's disease. Six databases (MEDLINE, CINAHL, PsycArticles, SPORTDiscus, EMBASE, CNKI) were searched from inception to October 2021. 16 articles with 945 participants (aged 70 to 88 years, 34.6% male) were included. Effects were pooled with a random-effects model (standardized mean difference, 95% CI).

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Physical activity improved global cognition (SMD 0.41, 95% CI 0.24-0.58, p < 0.01) compared with controls.
  2. 2
    Activities of daily living also improved (SMD 0.56, 95% CI 0.32-0.79, p < 0.01).
  3. 3
    In subgroup analyses, activity 3-4 times per week for 30-45 min over more than 12 weeks had a relatively strong effect on global cognition.
  4. 4
    Sensitivity analysis showed robust results, and the authors link the benefit to aerobic and mixed (aerobic plus anaerobic) exercise.

Limits & uncertainty

  1. 1
    Only 16 trials and 945 participants, and the abstract does not report heterogeneity or risk of bias in those trials.
  2. 2
    The best-schedule finding comes from subgroup analyses across trials, so it is suggestive rather than proven.
  3. 3
    Participants were aged 70 to 88 years and mostly women (34.6% male); the abstract does not say how severe their disease was.
  4. 4
    This reading is based on the abstract only.

What to take from it

For people with Alzheimer's disease, regular supervised aerobic or mixed exercise appears to be associated with modest gains in thinking and daily function. It does not prove a particular schedule is best. Exercise plans for someone with dementia should be set with their care team.

Reading your own data

For a person with Alzheimer's disease, a caregiver may track weekly sessions, steps or active minutes on a simple device. Compare against their own recent baseline, not against others.

How to read this evidence

Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Objective

The purpose of this meta-analysis was to examine the effects of physical activity (PA) on cognition and activities of daily living in adults with Alzheimer's Disease (AD).

Methods

Six electronic databases (MEDLINE, CINAHL, PsycArticles, SPORTDiscus, EMBASE and CNKI) were used to search for potential studies from inception until October 2021. Randomized controlled trials (RCTs) investigating the effect of physical activity (PA) on cognition and activities of daily living in AD patients compared to a control condition were included. The effect sizes were synthesized using a random effects model with a 95% confidence interval (CI).

Results

Sixteen articles including 945 participants (aged 70 to 88 years, 34.6% male) met the inclusion criteria. The pooled effect sizes demonstrated that PA intervention was associated with significant improvements in global cognition (Standard Mean Difference (SMD) = 0.41, 95% CI [0.24, 0.58], p < 0.01) and activities of daily living (SMD = 0.56, 95% CI [0.32, 0.79], p < 0.01) in AD patients. Subgroup analyses suggested that PA for 3-4 times per week for 30-45 min for more than 12 weeks had a relatively strong effect on improving global cognition in AD patients. The sensitivity analysis showed robust results.

Conclusions

The findings from the current meta-analysis suggested that AD patients can improve their global cognition and Activities of Daily Living (ADL) through engaging in aerobic and mixed exercise (aerobic and anaerobic exercise).

Sources & attribution

Physical Activity Improves Cognition and Activities of Daily Living in Adults with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Zhou S, Chen S, Liu X, Zhang Y, Zhao M, Li W.

International journal of environmental research and public health · 2022-01-22

DOI: 10.3390/ijerph19031216 ↗PubMed · 35162238 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000

Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.

The Lancet Public Health

In-depth explainersRead study →
·Cohort study

Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers

Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.

Nature Medicine

In-depth explainersRead study →
·Observational meta-analysis

Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)

Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.

The Lancet Public Health

In-depth explainersRead study →
·Observational meta-analysis

Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality

In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.

BMJ

In-depth explainersRead study →
Activity & longevity →